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Abstract
Background: Dengue is the most prevalent mosquito borne infection worldwide. Vertical transmissions after maternal
dengue infection to the fetus and pregnancy losses in relation to dengue illness have been reported. The relationship of
dengue to miscarriage is not known.
Method: We aimed to establish the relationship of recent dengue infection and miscarriage. Women who presented with
miscarriage (up to 22 weeks gestation) to our hospital were approached to participate in the study. For each case of
miscarriage, we recruited 3 controls with viable pregnancies at a similar gestation. A brief questionnaire on recent febrile
illness and prior dengue infection was answered. Blood was drawn from participants, processed and the frozen serum was
stored. Stored sera were thawed and then tested in batches with dengue specific IgM capture ELISA, dengue non-structural
protein 1 (NS1) antigen and dengue specific IgG ELISA tests. Controls remained in the analysis if their pregnancies continued
beyond 22 weeks gestation. Tests were run on 116 case and 341 control sera. One case (a misdiagnosed viable early
pregnancy) plus 45 controls (39 lost to follow up and six subsequent late miscarriages) were excluded from analysis.
Findings: Dengue specific IgM or dengue NS1 antigen (indicating recent dengue infection) was positive in 6/115 (5?2%)
cases and 5/296 (1?7%) controls RR 3?1 (95% CI 1?0–10) P=0?047. Maternal age, gestational age, parity and ethnicity were
dissimilar between cases and controls. After adjustments for these factors, recent dengue infection remained significantly
more frequently detected in cases than controls (AOR 4?2 95% CI 1?2–14 P=0?023).
Interpretation: Recent dengue infections were more frequently detected in women presenting with miscarriage than in
controls whose pregnancies were viable. After adjustments for confounders, the positive association remained.
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Introduction
Each year there is an estimated 100 million dengue infections [1],
500 thousand hospitalisations due to severe dengue illness [2] and
25 thousand dengue deaths [1] worldwide. Dengue’s geographical
reach is expanding [3] due in part to the complex interplay of
climate warming [4] coupled with travel and trade [5] impacting on
the observed extension in the range of the responsible mosquito
vector [6]. Dengue’s intensity in endemic areas has also increased
due to the spread of urbanisation [3].
Dengue illness is causedbyanyoneof four serotypes. Infection by
one serotype is thought to produce lifelong immunity to that se-
rotype but confers only a few months immunity to the others [7].
Secondary infection by a different serotype increases the risk of
severe illness [8]. Typically, dengue infection is asymptomatic or
minimally symptomatic in 87% of cases [9]. Hence, obvious dengue
illness is the tip of the iceberg in dengue infection.
In Malaysia where dengue is hyperendemic, all four serotype
circulate concurrently [10]. In a recent report on a national sample
of 1000 Malaysian adults aged 35–74, the dengue seroprevalence
rate was 91.6% with a positive age related trend [11].
Severe dengue illness during pregnancy is associated with major
adverse outcome of maternal deaths [12,13], perinatal deaths [12–14],
preterm births [12,14] and haemorrhages in labour with much of the
data from case reports and small case series [15]. In a large prospective
study of recent dengue infection detected at delivery, the pregnancy
outcome of 63 parturients who were dengue IgM positive is not
different from 2468 IgM negative controls [16]. Vertical transmission
to the fetus (particularly later in pregnancy) is established [15]. The
vertical transmission rate of maternal dengue infection can vary from
at least 1?6% [16] to 6?8% [17] based on prospective studies.
Miscarriages have been reported in association with dengue
illness [13,14,18,19] but it is not clear whether the miscarriages were
secondary to profound systemic disturbance as a consequence of
severe dengue illness or to vertically transmitted dengue infection.
Little is known on the effect of dengue infection in early pregnancy
with regard to the risk of miscarriage. According to a recent review,
pregnancy does not appear to increase incidence or severity of
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studies of dengue infection on pregnancy available [20].
Dengue specific immunoglobulin M (IgM) can be detected as
early as the second day of symptoms and for up to three months
[21]. The IgM level typically peaks on the sixth day [22] reaching
100% detection by the eighth day [23]. The dengue IgM test cross-
reactsacrossallfourdengueserotypes[24]and isproducedevenina
secondary infection [25]. The dengue non structural protein 1 (NS1)
antigen test is designed to diagnose all serotypes of dengue infection
from Day 1 to Day 9 [22]. Dengue IgG antibodies is detected in
100% of cases by Day 15 of primary infection [23] and its presence
without other evidence for acute infection is usually taken as distant
exposure to any combination of the four dengue serotypes.
We hypothesise that miscarriage is associated with exposure to
dengue during early pregnancy due either to maternal dengue il-
lness or vertical transmission. We sought to evaluate the prevalence
of recent dengue infection (using dengue IgM and NS1 tests) in
women presenting with miscarriage and in similar gestation women
with viable pregnancy and to estimate the relative risk of mis-
carriage in women recently exposed to dengue infection.
Methods
Ethics statement
Ethics approval for the study was obtained from the University
of Malaya Medical Centre Medical Ethics committee (approval
no. 715.25 dated 22
nd April 2009). The study was conducted in
keeping with the Declaration of Helsinki (amended Seoul, Korea
2008) on human study.
We performed a prospective matched case control study on
women who presented to our city-based university hospital with
miscarriageandcontrolwomenattendingourhospitalforpregnancy
related care whose pregnancy was viable. Relevant care providers in
our hospital were briefed about the study and requested to contact
the research team when they diagnosed a miscarriage at up to 22
weeks gestation sothat the patient can be approached and consented
for study enrolment. All participants provided their written consent.
Participants
From 9 June 2009 to 16 March 2011, women who presented
acutely to our hospital and diagnosed as a miscarriage were ap-
proached. For the purpose of the study, miscarriage is defined as the
presence of non-viable product of conception on ultrasound or
physical confirmation of expelled products and a positive pregnancy
test.Intheeventofearlymiscarriage, a positiveurinepregnancytest
and a history of expelled products of conception is also acceptable if
the uterus is empty at presentation. Gestation should not be more
than 22 weeks. Gestation is calculated from the reported first day of
the last menstrual period and corrected by ultrasound assessment
when deemed clinically appropriate to do so. We excluded women
with ectopic pregnancy or whose pregnancy was of unknown
location. For every case with miscarriage, we recruited three control
women with viable pregnancies matched for maternal age (within 3
years) and gestational age (within 3 weeks). The controls were
recruited at the earliest opportunity after the index miscarriage case
by a researcher (MZS) from amongst women attending for their
pregnancy care at our hospital. Miscarriage cases and controls were
derived from the same providers and hospital sources.
Procedures
All participants answered a short questionnaire about whether
they had a clinical diagnosis of dengue, made during the current
pregnancy or in their lifetime prior to the current pregnancy or a
febrile illness, in the last 10 days or at any juncture in their current
pregnancy.
Venous blood (5 ml) was collected from each participant and
drawnintoplainbloodbottles. Theblood samples were sent directly
to the laboratory for immediate processing or kept in a refrigerator
at 4uC prior to transfer if the laboratory was closed. The laboratory
is based at our university with extensive experience in dengue work.
Samples were discarded if after centrifugation, the supernatant
hadtheappearanceoflysedblood.Thespunsampleswerealiquoted
and then stored at 270uC. Sera weretested for dengue specific IgM,
dengue NS1 antigen and dengue specific IgG. Thesetests crossreact
against all four dengue serotypes.
Dengue specific IgM was tested for using an in-house IgM capture-
ELISA(enzymelinked immunosorbentassay)test[26].Sampleswere
considered positive if the ratio of optical density of the positive to
negative control was at least two. Panbio Dengue Early ELISA
Catalogue No. E-DEN02P (Inverness Medical Innovations Australia
Pty Ltd, Queensland, Australia) kits were used as a dengue NS1
antigen capture ELISA test. For dengue IgG detection, we used
Panbio Dengue IgG Indirect ELISA catalogue No. E-DEN01G
(Inverness Medical Innovations Australia Pty Ltd, Queensland,
Australia) kits. The Panbio kits were utilised as per manufacturer’s
instructions.
We define a recent dengue infection as the detection in sera of
dengue specific IgM and/or NS1 antigen.
The miscarriage cases had their chart reviewed up to their
discharge from hospital follow up. All included cases must have a
confirmed diagnosis of miscarriage at hospital discharge. Cases who
did not attend any hospitalfollow upsubsequentto theirrecruitment
into the study or whose latest follow up data were still inconclusive
for a diagnosis of miscarriage were contacted by telephone at least
three months after their recruitment to confirm the diagnosis of
miscarriage with a view to excluding those with a misdiagnosis.
Similarly, controls that did not have confirmation of pregnancy
viability beyond 22 weeks gestation from chart review because they
transferred care elsewhere were contacted by telephone to confirm
pregnancy viability beyond 22 weeks gestation.
We had planned to exclude controls that could not be confirmed
to have a viable pregnancy beyond 22 weeks as we could not
Author Summary
Dengue is the most prevalent mosquito-borne infection
with two billion of the world’s population at risk and 100
million infections every year. Dengue is increasingly
important due to expansion in the vector’s range,
increased population density in endemic areas from
urbanisation, social and environment change. Miscarriage
and stillbirth is associated with dengue when the illness is
severe. Dengue can also be transmitted directly from the ill
mother through the placenta to the fetus in later
pregnancy with variable effect to the fetus. However,
dengue infection is asymptomatic to mild only in almost
90% of cases and up to 20% of pregnancies miscarry. Little
is known if dengue infection in early pregnancy particu-
larly when it is asymptomatic or mild has an effect on
miscarriage. Our study explored the relationship between
dengue and miscarriage by looking at recent infection
rates amongst women who had miscarried and those
whose pregnancies were healthy in an area were dengue is
common. Our study finds a positive association between
recent dengue infection and miscarriage. This finding may
be important in explaining some of the miscarriages in
areas where dengue is common. It is also relevant to newly
pregnant women from non-dengue travelling to dengue
endemic areas.
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to evaluate miscarriages up to 22 weeks gestation; it would be
inappropriate to have as controls, women who subsequently had
miscarriages. We excluded controls who had miscarried after re-
cruitment as we could not exclude a new dengue infection around
the time of their miscarriage as no dengue testing was done then.
Sample size calculation
In a recent study on parturients performed at our hospital, the
maternal dengue infection rate as defined by a positive dengue IgM
test was 2?5% [16]. Since pregnancy per se has no effect on the
acquisition of dengue infection, we expect our control population to
have a 2?5% recent dengue infection rate and for the purpose of the
sample size calculation we postulate that miscarriage cases will have
a 10% recent dengue infection rate. Taking alpha of 0?05, 80%
power, 1 to 2 case to control ratio (using PS sample size calculator)
[27], 112 cases and 224 controls are required, . As we expect sig-
nificant attrition in the number of controls due to care transfer to
other institutions and hence their drop out from follow up, we
increased our planned recruitment ratio to 1 case to 3 controls i.e. at
least 112 miscarriage cases and 336 viable pregnant controls.
Statistical analysis
Data wasentered intoSPSSversion 15(SPSSInc.SanDiego CA
USA). Comparison (between cases and controls) of the means of
continuous variables was by the Student t test, ordinal variables by
the Mann Whitney U test and categorical variables by the Chi
square test. Fisher exact test is used in place of the Chi Square test
for categorical variables if 2 or more cells contain ,5 subjects.
Multivariable logisticregressionanalysis,incorporatinginthe model
all characteristics with P,0?05 on bivariate analyses between cases
and controls was performed to adjust for these differences in order
to establish their independent association with miscarriage. All tests
were 2-sided and P,0?05 was taken as a level of significance.
Results
Figure 1 depicted the flow of the recruits within the study and
their eventual destination. We recruited and drew blood from 116
caseswith adiagnosisofmiscarriageand 348similargestationalaged
controls whose pregnancies were viable at recruitment, totalling 464
women for thestudy cohort. Bloodsamples fromseven controlswere
found tobelysed afterprocessinganddiscarded,leaving457samples
Figure 1. Flow chart of recruits with miscarriages (up to 22 weeks) and controls through the study.
doi:10.1371/journal.pntd.0001637.g001
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one case of miscarriage was found to be a misdiagnosis and that
pregnancy resulted ina term livebirth. Six controls miscarried before
22 weeks gestation and another 39 controls could not be confirmed
to have a viable pregnancy beyond 22 weeks gestation despite
attempted contact by telephone. These 46 women were excluded
from the final analysis.
The characteristics of included cases and controls are shown in
Table 1. Prevalence of recent dengue are 5?3% and 1?7%; RR 3?1
(95% 1?0–10) P=0?047 in cases versus controls. Cases with mis-
carriages on bivariate analyses were also more likely to be older, of
higher gestational age at recruitment and parity and less likely to
belong to our major ethnicities of Malay, Chinese or Indian but not
significantly more likely to have been ill with a fever during their
pregnancy nor more likely to have had distant exposure to dengue
(dengue IgG positive status). All the characteristics with P,0?05 on
bivariate analysis were included in the model for multivariable
logisticregressionanalysis.Afteradjustment,recentdengueinfection
remained an independent risk factor for miscarriage; adjusted odds
ratio AOR 4?2 (95% Confidence Interval 1?2–14) P=0?023.
As a post hoc analysis, if all participants with available dengue
test results (n=457) were analysed, excluding only the seven with
lysed samples, the result is not altered: recent dengue infection is
still a significant independent risk factor for miscarriage (AOR 3?8
95% CI 1?2–13 P=0?026).
The 11 participants from both arms of the study group who had
recent dengue infection were of similar age, gestational age, parity
status, prior miscarriage status, ethnicity and personal awareness
of dengue diagnosis in the past but as anticipated, more likely to
report a recent febrile illness (as dengue illness is typically febrile)
and to be dengue IgG positive (as IgG conversion follows IgM
response within a week or two in primary infections) compared to
the 400 without evidence of recent dengue – Table 2. These
findings support the perception that in our environment with
dengue hyperendemicity, dengue is an equal opportunity infection
amongst pregnant women.
Four of the five controls with recent dengue infection reported a
febrile illness during pregnancy compared to two such reports
amongst the six miscarriage cases. All five controls with recent
dengue infection and known outcome proceeded to livebirths at
term. In the six miscarriage cases, there was one case of concurrent
miscarriage and severe dengue illness. That case required intensive
care therapy during her hospitalisation but her miscarriage just
preceded the worst of the dengue illness. These findings are not
helpful in differentiating whether dengue illness or vertical dengue
infection contributed more to the abortion process.
Table 1. Characteristics of a total of 411 cases (confirmed miscarriages up to 22 weeks) and controls (pregnancies that remained
viable beyond 22 weeks at follow up).
Characteristics Cases Controls Relative Risk P value Adjusted Odds Ratio Adjusted P value
n=115 n=296
(95% Confi
dence Interval)
(95% Confidence
Interval)I
Recent dengue infection (dengue
IgM and/or NS1 antigen positive)*{
6( 5 ?2%) 5 (1?7%) RR 3?1( 1 ?0–10) P=0?047 AOR 4?2( 1 ?2–14) P=0?023
Dengue IgM antibody positive* 6 (5?2%) 3 (1?0%) RR 5?2( 1 ?3–20) P=0?009
Dengue NS1 antigen positive* 1 (0?9%) 2 (0?7%) RR 1?3( 0 ?1–14) P=0?836
Dengue IgG antibody positive* 63 (54?8%) 150 (50?7%) RR 1?1( 0 ?9-1?3) P=0?454
Maternal age (years){ { 31?465?72 9 ?464?5P = 0 ?001 AOR 1?1( 1 ?0-1?1) P=0?011
Gestation (weeks) at recruitment{{ 12?464?01 1 ?463?5P = 0 ?009 AOR 1?1( 1 ?0-1?2) P=0?004
Parity1{ 1 [0–2] 0?5 [0–2] P=0?018 AOR 1?1( 0 ?9-1?3) P=0?564
Prior miscarriages (number)1 0 [0–1] 0 [0–1] P=0?985
Ethnicity*{ P=0?020
Malay 83(72?2%) 230 (77?7%) AOR 0?2( 0 ?1-0?7) P=0?005
Indian 14 (12?2%) 41 (13?9%) AOR 0?3( 0 ?1-0?7) P=0?011
Chinese 5 (4?3%) 15 (5?1%) AOR 0?2( 0 ?1-0?9) P=0?038
Others 13 (11?3%) 10 (3?4%)
Diagnosis of dengue infection in
life time before current pregnancy*
6( 5 ?2%) 26 (8?8%) RR 0?6( 0 ?3-1?4) P=0?226
Diagnosis of dengue infection
during pregnancy*
1( 0 ?9%) 1 (0?3%) RR 2?6( 0 ?2-41) P=0?487
Febrile illness in the 10 days prior to
enrolment into study*
8( 7 ?0%) 12 (4?1%) RR 1?7( 0 ?7-4?1) P=0?220
Febrile illness at any time
during pregnancy*
8( 7 ?0%) 23 (7?8%) RR 0?9( 0 ?4-1?9) P=0?779
Data displayed as number (%), mean 6 standard deviation or median [interquartile range].
*Analysis using Chi Square test (categorical data).
{Included in logistic regression model.
{Analysis using Student t test (continuous data).
1Analysis using Mann Whitney test (non-normal data distribution).
IMultivariable logistic regression analysis incorporating into the model recent dengue infection and adjusting for maternal age, gestational age, parity, and ethnicity,
characteristics which are significantly associated with pregnancy miscarriage on bivariate analyses. Maternal age, gestational age and parity were entered as continuous
variable and recent dengue and ethnicity as categorical variables.
doi:10.1371/journal.pntd.0001637.t001
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The literature on dengue and miscarriage or spontaneous
abortion is sparse. We performed a PubMed (http://www.ncbi.
nlm.nih.gov/sites/entrez) search applying terms dengue and mis-
carriage or dengue and abortion without limitations on October 1,
2011 and retrieved only 11 reports. Of these 11 reports, only four
publications involved the study of miscarriages in association with
dengue, presenting anecdotal data on only five cases of miscarriage
during dengue illness [13,14,18,19]. A recent report on women in
refugee camps at the Thai-Burmese border investigating antenatal
febrileillnesshasfoundadengueinfectionrateof9.5%.Onewoman
(of 20; 5%) who had dengue associated fever during pregnancy
subsequently miscarried [28].
Recentdengueinfection was found in11/411(2?6%)ofourstudy
participants, a very similar rate to a recent report from our hospital
of 2?5% (63/2531) dengue IgM rate in unselected parturients at
time of their delivery [16]; (Chi Square test, P=0?82). This shows
that as a whole, the participants of our current study closely reflect
unselected parturients at our hospital with regard to the risk of
recent dengue infection and supports the assertion that the selection
of our study group is unbiased. The similar dengue IgG positive and
reported recent febrile illness rates amongst cases and controls in
our current study further bolster the above assertion.
Our dengue IgG positive rate of 213/411 (52%) indicating prior
dengue exposure in participants whose mean age was 30 years old is
similar to the 63% dengue IgG positive rate from a cross sectional
community-based prevalence study on subjects aged 21 to 40 years
[29] who were derived from the same geographical catchment area
as our participants. This similarity lends support to our study group
as a whole being a representative sample of the host population.
It is noteworthy that 6/11 (54?5 % )o ft h ew o m e nw i t hr e c e n t
dengue in our sample reported a febrile illness in the course of the
pregnancy leading up to their recruitment at a mean gestation of
only10?8 weeks whereas in an earlier study at our hospital of 63
dengue IgM positive parturients (delivered at a mean gestation of
39?4w e e k ) ,o n l y7 / 6 3( 1 1 ?1%) reported a febrile illness over the
entire course of pregnancy [16]; (Chi Square test P,0?001). Dengue
is reported to be asymptomatic or minimally symptomatic in 87% of
infections [9], an illness rate similar to that reported by the parturients
but far lower than in our current study group. Mild exposures to
hyperthermia or fever during the preimplantation period and more
severe exposures during embryonic and fetal development often re-
sultin prenatal death and abortion [30]. The possibleinterpretation is
that dengue infection in very early pregnancy may give rise to a more
symptomatic (or severe) presentation. This more severe effect may
contribute to its role in miscarriage whereas dengue infection late in
pregnancy is far less likely to be severe and thus did not adversely
affect on delivery outcome [16]. However, with only 11 cases of
recent dengue found in this study, further corroboration of this
hypothesis is required.
Although dengue illness cancause fatigue at two months [31] and
otherpersistentsymptomsat twoyears [32]beyond theacute phase,
all fivecases of recent dengue infection in our control group resulted
in term livebirths despite the fact that four of these five had reported
a febrile illness during early pregnancy. The interpretation might be
that dengue infection very early on during pregnancy may have a
severe impact sufficient to contribute to early miscarriage but does
not have a prolonged adverse effect deeper into pregnancy.
There are limitations in our study design. As dengue IgM may
persist for up to six months [1] after infection though rarely, our
methodology was not capable of identifying only those dengue
infections that were within pregnancy – some those identified with
recent dengue infection might havebeen infectedpriorto pregnancy.
Specific IgM might not be detectable in a small proportion of se-
condary infections [1,25] and given the dengue IgG detection rate
Table 2. Characteristics of women with and without recent dengue infection.
Characteristics Dengue* No dengue Relative risk P value
n=11 n=400
(95% Confid
ence Interval)
Maternal age (years)
{ 29?465?23 0 ?065?0P = 0 ?700
Gestation (weeks) at recruitment
{ 10?862?31 1 ?763?7P = 0 ?258
Parity
{ 0 [0–1] 1 [0–2] P=0?631
Prior miscarriages (number)
{ 0 [0–1] 0 [0–1] P=0?455
Ethnicity
1 P=0?410
Malay 10 (90?9%) 303 (75?8%)
Indian 0 (0?0%) 55 (13?8%)
Chinese 1 (9?1%) 19 (4?8%)
Others 0 (0%) 23 (5?8%)
Dengue IgG positive 9 (81?8%) 204 (51?0%) RR 1?6( 1 ?2-2?2) P=0?044
Diagnosis of dengue infection in life time before pregnancy
I 1( 9 ?1%) 31 (7?8%) RR 1?2( 0 ?2-7?8) P=0?870
Diagnosis of dengue infection during pregnancy
1 1( 9 ?1%) 1 (0?3%) RR 36 (2?4–544) P=0?053
Febrile illness in the 10 days prior to enrolment into study
I 4( 3 6 ?4%) 16 (4?0%) RR 9?1( 3 ?6–22?8) P,0?001
Febrile illness at any time during pregnancy
I 6( 5 4 ?5%) 25 (6?3%) RR 8?7( 4 ?5–16?9) P,0?001
Data displayed as mean 6 standard deviation, median [interquartile range] or number (%).
*Defined as women whose sera were dengue IgM positive and/or dengue NS1 particle positive.
{Analysis using Student t test (continuous data).
{Analysis using Mann Whitney U test.
1Analysis using Fisher exact test (2 or more cells with numbers ,5).
IAnalysis using Chi Square test.
doi:10.1371/journal.pntd.0001637.t002
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infection we detected were secondary infections. However, these
limitations apply to both cases and controls, so should not affect the
assessment of relative risk and if anything, would be biased against
the finding of a relationship between recent dengue and miscarriage.
Our IgM capture ELISA assay for dengue cross reacts with IgM
against other flaviviruses notably Japanese encephalitis and Yellow
fever viruses but IgM capture ELISA for dengue has demonstrated
onlyalow crossreactivitywithJapaneseEncephalitisvirus[33].Both
yellow fever and viral encephalitis were very rare in Malaysia with a
reported rate in2010 of0 per 100000 and 0?2per100000population
respectively compared to dengue illness rate of 148?7 per 100000
population [34]. With only 11 recent dengue infections identified
from a sample of 411 (2?6%), the recent dengue infection rate in our
study is somewhat lower than that assumed in our sample size
calculation of 2?5% recent dengue infection rate in controls and an
assumed 10% in miscarriage cases. As a consequence, although
analysis shows a significant association between dengue infection and
miscarriage at the 5% level of significance, the relatively small
numberof infections means that the 95% confidenceinterval is wide.
In summary, in the context of our setting with dengue hy-
perendemic, 5?2% of the women with miscarriages displayed evi-
dence of recent dengue infection compared to 1?7% in controls with
viable pregnancies (AOR 4?2 95% CI 1?2–14: P=0?023), a
statistically significant and clinically important finding. This interac-
tion between dengue infection in early pregnancy and miscarriage is a
highly relevant public health issue due to high number of dengue
infections worldwide annually and the typically higher fertility rates in
the dengue endemic regions of the world. There is an implication also
for travellers from dengue free regions in the early stages of their
pregnancies who are journeying to dengue endemic areas. Further
study to replicate our data and finding is urgently needed.
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